Arcellx Inc (ACLX)
82.76
-1.38
(-1.64%)
USD |
NASDAQ |
Sep 27, 16:00
82.73
-0.03
(-0.04%)
After-Hours: 20:00
Arcellx Total Liabilities (Quarterly): 247.14M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 247.14M |
| March 31, 2024 | 283.12M |
| December 31, 2023 | 339.75M |
| September 30, 2023 | 348.09M |
| June 30, 2023 | 329.86M |
| March 31, 2023 | 319.23M |
| December 31, 2022 | 108.86M |
| Date | Value |
|---|---|
| September 30, 2022 | 101.04M |
| June 30, 2022 | 59.37M |
| March 31, 2022 | 21.80M |
| December 31, 2021 | 250.30M |
| September 30, 2021 | 248.76M |
| December 31, 2020 | 121.41M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.80M
Minimum
Mar 2022
348.09M
Maximum
Sep 2023
213.75M
Average
248.76M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 109.55B |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 734.31M |
| Shareholders Equity (Quarterly) | 487.16M |
| Current Ratio | 6.005 |